{"a":[{"_":"Osivax bags flu vaccine rights to pursue combination shot vision","$":{"href":"/biotech/osivax-bags-flu-vaccine-rights-pursue-combination-shot-vision","hreflang":"en"}}]}

Summary

Osivax has licensed an influenza vaccine from GC Biopharma to develop a combination shot. The deal positions Osivax to advance a midphase candidate that early evidence suggests complements traditional flu vaccines.